Our goal was to evaluate the effects of simvastatin on endometrial cancer cell lines and primary cultures of endometrial cancer cells
Ovarian clear cell carcinomas (OCCC) constitute a rare subtype of epithelial ovarian cancer, lacking...
Advanced/metastatic or recurrent endometrial cancer has a poor prognosis. Malignant endometrial tiss...
Abstract Background Simvastatin is a promising new drug for the treatment of endometriosis. It is a ...
Our goal was to evaluate the effects of simvastatin on endometrial cancer cell lines and primary cul...
Ovarian cancer is the 5th leading cause of cancer death among women in the United States. The mevalo...
Ovarian cancer is the 8th most common cancer in women, and the 5th leading cause of cancer-related d...
Ovarian cancer is the fifth most common cancer which affects women in the United Kingdom. The 5-year...
FAPESP - FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULOCAPES - COORDENAÇÃO DE APERFEIÇOAMENTO ...
To examine the effects of combination therapy with metformin and paclitaxel in endometrial cancer ce...
Despite adequate surgery, women affected by advanced-stage gynaecological cancers (ovarian/ endometr...
Renal cell carcinoma (RCC) is the most lethal type of genitourinary cancer due to its occult onset a...
Lipophilic statins purportedly exert anti-tumoral effects on breast cancer by decreasing proliferati...
Renal cell carcinoma (RCC) is the most lethal type of genitourinary cancer due to its occult onset a...
Lung cancer is the most common cause of cancer-related death. Nonetheless, a decrease in overall inc...
Epithelial ovarian cancer (EOC) is the most lethal gynecological cancer and often is not detected un...
Ovarian clear cell carcinomas (OCCC) constitute a rare subtype of epithelial ovarian cancer, lacking...
Advanced/metastatic or recurrent endometrial cancer has a poor prognosis. Malignant endometrial tiss...
Abstract Background Simvastatin is a promising new drug for the treatment of endometriosis. It is a ...
Our goal was to evaluate the effects of simvastatin on endometrial cancer cell lines and primary cul...
Ovarian cancer is the 5th leading cause of cancer death among women in the United States. The mevalo...
Ovarian cancer is the 8th most common cancer in women, and the 5th leading cause of cancer-related d...
Ovarian cancer is the fifth most common cancer which affects women in the United Kingdom. The 5-year...
FAPESP - FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULOCAPES - COORDENAÇÃO DE APERFEIÇOAMENTO ...
To examine the effects of combination therapy with metformin and paclitaxel in endometrial cancer ce...
Despite adequate surgery, women affected by advanced-stage gynaecological cancers (ovarian/ endometr...
Renal cell carcinoma (RCC) is the most lethal type of genitourinary cancer due to its occult onset a...
Lipophilic statins purportedly exert anti-tumoral effects on breast cancer by decreasing proliferati...
Renal cell carcinoma (RCC) is the most lethal type of genitourinary cancer due to its occult onset a...
Lung cancer is the most common cause of cancer-related death. Nonetheless, a decrease in overall inc...
Epithelial ovarian cancer (EOC) is the most lethal gynecological cancer and often is not detected un...
Ovarian clear cell carcinomas (OCCC) constitute a rare subtype of epithelial ovarian cancer, lacking...
Advanced/metastatic or recurrent endometrial cancer has a poor prognosis. Malignant endometrial tiss...
Abstract Background Simvastatin is a promising new drug for the treatment of endometriosis. It is a ...
DOI
Add to ORKG